Recent news items relate primarily to commodity price movements and broader market themes rather than company-specific developments.

• Higher Brazil sugar production has weighed on sugar prices, impacting commodity markets relevant to the company’s business environment [N1].
• Sugar prices have slipped due to increased production in Brazil, reflecting market supply dynamics [N8].
• The ARK Innovation ETF’s vision for the future highlights themes in innovation and technology that align with sectors targeted by the company [N2].
• Discussions on retirement and social security reflect broader economic considerations affecting consumer behavior [N3].
• Market commentary on artificial intelligence suggests evolving investor sentiment in technology sectors [N4].

The company’s management team has demonstrated success in backing category leaders in niche and emerging sectors, which may enable it to identify and complete a Business Combination with a high-growth target. The company’s focus on harm-reduction innovation, wellness, and technology-enabled platforms aligns with growing market trends. Its substantial capital in trust and flexible transaction structuring options provide financial strength to support a successful combination. Post-combination, the company intends to actively support the target’s strategic execution, potentially enhancing value creation.

The company has not yet identified a Business Combination target, and the success of its business model depends entirely on completing such a transaction. Geopolitical instability, including conflicts in Ukraine and the Middle East, may adversely affect its ability to consummate a Business Combination or the operations of any target. Market volatility and potential delisting risks if the Business Combination is not completed by February 2028 pose additional challenges. The company’s lack of operating history and dependence on a single transaction increase execution risk.

As a SPAC, Cambridge Acquisition Corp. does not have an operating business moat but leverages its management team's proven track record in stigmatized and under-served markets, extensive founder and operator networks, and operational and transactional expertise. This experience and network provide proprietary deal flow and the ability to engage with high-caliber management teams early, which may offer competitive advantages in sourcing and executing a Business Combination. The company’s flexibility in structuring transactions and its substantial capital base further support its ability to compete for attractive targets.

• Geopolitical and Market Risks: Ongoing conflicts in Ukraine and the Middle East, along with resulting sanctions and market disruptions, may adversely affect the company’s ability to identify and complete a Business Combination and impact the operations of any target business [S2].
• Business Combination Completion Risk: Failure to complete an initial Business Combination by February 9, 2028, may lead to Nasdaq suspension and delisting, reducing liquidity and market attractiveness [S2].
• Dependence on Single Transaction: The company’s success depends entirely on completing a Business Combination with a suitable target; failure to do so would materially affect its prospects [S1][S2].
• Uncertainty of Target Business Performance: The company has not identified a target and cannot assure the financial condition, business prospects, or risks of any future target [S2].
• Potential Amendments to Agreements: Certain agreements related to the IPO may be amended without shareholder approval, potentially affecting shareholder interests [S2].

• Cambridge Acquisition Corp. is a Cayman Islands-incorporated Special Purpose Acquisition Company (SPAC) listed on Nasdaq under ticker CAQ [S1].
• The company completed its IPO and Private Placement in early 2026, raising approximately $230 million placed in a trust account for use in an initial Business Combination [S1][S2].
• As of March 31, 2026, the company had current assets of $1,095,789 and current liabilities of $100,267, resulting in a strong current ratio of 10.93, indicating high short-term liquidity [S2].
• The company reported net income of $510,262 for the quarter ended March 31, 2026 [S2].
• The company had a basic and diluted EPS of -$0.01 for the fiscal year ended December 31, 2025 [S1].
• Cambridge Acquisition Corp. has no operating business and intends to complete an initial Business Combination with a target company, focusing on sectors involving harm-reduction innovation, wellness-oriented products, and technology-enabled platforms primarily in the US and Europe but not limited geographically [S1].
• The management team has a track record in stigmatized and under-served markets, with experience in backing category leaders and executing transactions including SPAC business combinations [S1].
• The company’s strategy includes leveraging operational guidance, capital resources, and public market access to accelerate growth and governance of the target business post-combination [S1].
• The company has flexibility in structuring the Business Combination using cash, debt, equity securities, or combinations thereof [S1].
• The company’s securities include Class A Ordinary Shares (CAQ), Units (CAQUU), and Redeemable Warrants (CAQUW) all listed on Nasdaq [S1].
• The company is a smaller reporting company and an emerging growth company, with certain reduced reporting requirements [S1][S2].
• The company faces risks related to geopolitical instability, including conflicts in Ukraine and the Middle East, which may affect its ability to consummate a Business Combination and the operations of any target business [S2].
• The company has until February 9, 2028, to complete its initial Business Combination or face potential delisting from Nasdaq [S2].
• The company may seek to extend the Combination Period subject to shareholder approval, which could reduce funds available in the trust account and affect its ability to complete a Business Combination [S2].
• The company’s management may amend certain agreements related to the IPO without shareholder approval, which could affect shareholder interests [S2].
• The company has not yet identified a specific Business Combination target and has not initiated substantive discussions with any target [S2].
• The company’s business model depends entirely on the successful identification and completion of a Business Combination with a target company [S1][S2].
• Recent news items related to the company’s business environment include commodity price movements such as higher Brazil sugar production weighing on prices [N1][N8].